Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Invion.
RELATED STOCKHEAD STORIES
News
ASX Lunch Wrap: ASX takes historic leap to 8500 level; Zip co-founder Larry Diamond exits
Health & Biotech
Health Check: Let there be light (therapy). Invion up 160pc on skin cancer trial news
Health & Biotech
Biocurious: Invion taps the power of light to zap solid tumours
News
Top 10 at 11: A real mixed bag to kick off the winner’s list for today
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX hits record, Nanoveu doubles on AI news, Tyro drops 10pc on new debit card proposal
News
ASX Small Cap Lunch Wrap: Banks and Resources have pushed ASX 200 to another record high
Health & Biotech
Health Check: It’s all in the vibe as Invion and Wellness Life shrink to share greatness
News
ASX Small Caps Lunch Wrap: Markets flat ahead of US rate call. It’s eerily quiet today
Health & Biotech
Health Check: Paradigm receives FDA guidance on proposed trial for dodgy knees
Health & Biotech
Alive and Kicking: Prescient Therapeutics chief passes CEO baton after eight years in the job
News
Closing Bell: ASX falls but lithium stocks rally big on China news; MinRes also jumps 17pc
News
ASX Small Caps Lunch Wrap: ASX dips despite Resources surge, as US/China slowdowns weigh
News
Top 10 at 11: Titanium sands, defence training and project progress is the news today
News
ASX Small Caps Lunch Wrap: US jobs sink the ASX; Steadfast caught in kickback scandal
News
Top 10 at 11: Air traffic control training is what’s in the news this morning
Experts
